Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-09-29
2011-11-15
Saoud, Christine J (Department: 1647)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S004000, C436S501000, C436S506000, C436S503000, C530S413000, C530S417000, C530S418000
Reexamination Certificate
active
08058014
ABSTRACT:
The present invention is directed to methods of diagnosing a disease or predicting an increased risk of a disease, such as obesity, obesity-dependent subacute inflammation, atherosclerosis, cardiovascular disease and a metabolic disease, by determining the levels of omentin 1 and 2 protein in a subject, or by determining the levels of omentin 1 and 2 gene expression in a subject. The present invention is also directed to methods of disease treatment using omentin 1 protein and omentin 2 protein.
REFERENCES:
patent: 6146849 (2000-11-01), Pierce et al.
patent: 6342581 (2002-01-01), Rosen et al.
patent: 6478825 (2002-11-01), Winterbottom et al.
patent: 6524820 (2003-02-01), Pierce et al.
patent: 6635255 (2003-10-01), Bruck et al.
patent: 7022493 (2006-04-01), Issakani et al.
patent: 7312197 (2007-12-01), Gong et al.
patent: 7550435 (2009-06-01), Gong et al.
patent: 2002/0173635 (2002-11-01), Jacobs et al.
patent: 2003/0064412 (2003-04-01), Fischer et al.
patent: 2003/0082533 (2003-05-01), Yue et al.
patent: 2004/0044191 (2004-03-01), Fischer et al.
patent: 2004/0220099 (2004-11-01), Gong et al.
patent: 2005/0032166 (2005-02-01), Chen et al.
patent: 2005/0112675 (2005-05-01), Kochan et al.
patent: 99/49033 (1999-09-01), None
patent: 99/60161 (1999-11-01), None
patent: 00/05367 (2000-02-01), None
patent: 00/66708 (2000-11-01), None
patent: 00/73454 (2000-12-01), None
patent: 01/16318 (2001-03-01), None
patent: 01/68848 (2001-09-01), None
http://en.wikipedia.org/wiki/Obesity; accessed on Mar. 12, 2011.
Yang et al., “cDNA Cloning, Genomic Structure, Chromosomal Mapping, and Functional Expression of a Novel Human Alanine Aminotransferase,” Genomics, Mar. 2002, 79(3), pp. 445-450.
Kashiwagi et al., “In Vitro Insulin Resistance of Human Adipocytes Isolated From Subjects with Noninsulin-Dependent Diabetes Mellitus,” J. Clin. Invest., Oct. 1983, 72(4), pp. 1246-1254.
Tsuji et al., “Human Intelectin is a Novel Soluble Lectin That Recognizes Galactofuranose in Carbohydrate Chains of Bacterial Cell Wall,” The Journal of Biological Chemistry, Jun. 2001, 276(26), pp. 23456-23463.
Lee et al., “Human Homologs of the Xenopus Oocyte Cortical Granule Lectin XL35,” Glycobiology, 2001, 11(1), pp. 65-73.
Suzuki et al., “Molecular Cloning and Functional Expression of a Human Intestinal Lactoferrin Receptor,” Biochemistry, 2001, 40, pp. 15771-15779.
Komiya et al., “Cloning of the Novel Gene Intelectin, Which is Expressed in Intestinal Paneth Cells in Mice,” Biochemical and Biophysical Research Communication, 1998, 251, pp. 759-762.
Altschul et al., Gapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programs, Nucleic Acids Research, 1997, 25, pp. 3389-3402.
NCBI Database Accession No. AAS49907, May 19, 2006.
Yang et al., Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action.Am J Physiol Endocrinol Metab290: E 1253-E1261, 2006.
De Souza Batista et al., Omentin Plasma Levels and Gene Expression Are Decreased in Obesity.Diabetes56:1655-1661 (2007).
Kralisch, S., et al. Adipokines and Adipocyte Targets in the Future Management of Obesity and the Metabolic Syndrome. Mini-Reviews in Medicinal Chemistry, 2007, 7:39-45.
Wurm, S., et al. Plasma levels of leptin, omentin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and adiponectin before and after oral glucose uptake in slim adults. Cardiovascular Diabetology 2007, 6:1-7.
Sharma AM: Adipose Tissue: a mediator of cardiovascular disease. Int J Obes 26:Suppl 4:S5-S7, 2002.
Felber JP, Golay A: Pathways from obesity to diabetes. Int J Obes 26:Suppl 2:S39-S45, 2002.
Kershaw EE, Flier JS: Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556, 2004.
Galuska DA, Khan LK: Obesity: a public health perspective. In Present Knowledge in Nutrition. 8th ed. Ed. International Life Sciences Institute, 2001, p. 531-542.
Bjorntorp P: Metabolic implications of body fat distribution. Diabetes Care 14:1132-1143, 1991.
Brunzell JD, Hokanson JE: Dyslipidemia of central obesity and insulin resistance. Diabetes Care 22:Suppl 3:C10-13, 1999.
Lemieux S: Contribution of visceral obesity to the insulin resistance syndrome. Can J Appl Physiol 26:273-290, 2001.
Johnson JA, Fried SK, Pi-Sunyer FX, Albu JB: Impaired insulin action in subcutaneous adipocytes from women with visceral obesity. Am J Physiol Endocrinol Metab 280:E40-E9, 2001.
Van Pelt RE, Jankowski CM, Gozansky WS, Schwartz RS, Kohrt WM: Lower-body adiposity and metabolic protection in postmenopausal women. J Clin Endocrinol Metab 90:4573-4578, 2005.
Fried SK, Ross, RJR: The biology of visceral adipose tissue. In Handbook of Obesity, 2nd edition, Edited by Bray GA, Bouchard C, James WPT, 2005, pp. 589-614.
Schaffler A, Neumeier M, Hertarth H, Furst A, Scholmerich J, Buchler C: Genomin structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 1732:96-102, 2005.
Kralisch S, Klein J, Bluher M, Paschke R, Stumvoll M, Fasshauer M: Therapeutic perspectives of adipocytokines. Expert Opin Pharmacother 6:863-72, 2005.
Fu M, et al. Systematic analysis of omentin 1 and omentin 2 on 1q23 as candidate genes for type 2 diabetes in the Old Order Amish (Abstract). Diabetes 53: A59, 2004.
St Jean P, et al. Association between diabetes, obesity, glucose and insulin levels in the Old Older Amish and SNPs on 1q21-23. Am J Hum Genet 67:332, 2000.
Elbein SC, et al. A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes 48:1175-1182, 1999.
Hanson RL, et al. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet 63:1130-1138, 1998.
Vionnet N, et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 67:1470-1480, 2000.
Wiltshire S, et al. A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet 69:553-569, 2001.
Hsueh WC, et al. Diabetes in the Old Order Amish: Characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care 23:595-601, 2000.
Almasy L, Blangero J: Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198-1211, 1998.
Stothard P: The Sequence Manipulation Suite: JavaScript programs for analyzing and formatting protein and DNA sequences. Biotechniques 28:1102-1104, 2000.
Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S: Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution, Diabetes 46:342-347, 1997.
Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I: Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46:860-867, 1997.
Arita Y, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83, 1999.
Yang WS, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86:3815-3819, 2001.
Weyer C, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935, 2001.
Tschritter O, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52:239-243, 2003.
Yamauchi T, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946, 2001.
McLaughlin T, Abbasi F, Kim HS, Lamendola C, Schaaf P,
Gong Da-Wei
McLenithan John C.
Shuldiner Alan R.
Yang Rong-Ze
Roylance Abrams Berdo & Goodman LLP
Saoud Christine J
University of Maryland Baltimore
LandOfFree
Method of diagnosing or predicting disease states in a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of diagnosing or predicting disease states in a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing or predicting disease states in a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4270987